VIVIEN ROSENBERGER: Open Payments
NPI 1376018366 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 81 payments from 16 companies in 2025. Trend: 2023 $2,301 · 2024 $2,168 · 2025 $1,666
Food & beverage: $1,659Education: $7
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $377 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $300 |
| Currax Pharmaceuticals LLC | 24 | $205 |
| PFIZER INC. | 17 | $184 |
| Corcept Therapeutics | 2 | $122 |
| Medtronic, Inc. | 1 | $118 |
| Vanda Pharmaceuticals Inc. | 2 | $56 |
| Novo Nordisk Inc | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
Products named: BREZTRI, Kerendia, CONTRAVE, NURTEC ODT, Korlym, MINIMED 780G, HETLIOZ, REXULTI.
Industry payments across KY — which companies pay providers there.
